Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetics of Levosimendan in Children With Acute Heart Failure

Trial Profile

Pharmacokinetics of Levosimendan in Children With Acute Heart Failure

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Oct 2018

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Acute heart failure; Chronic heart failure
  • Focus Pharmacokinetics
  • Acronyms LevoCorKids
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 20 Apr 2017 Planned End Date changed from 1 Nov 2016 to 1 Nov 2018.
    • 14 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top